Menu Close
  • Clinical
    • In the Literature
    • Key Clinical Questions
    • Interpreting Diagnostic Tests
    • Coding Corner
    • Clinical
    • Clinical Guidelines
    • COVID-19
    • POCUS
  • Practice Management
    • Quality
    • Public Policy
    • How We Did It
    • Key Operational Question
    • Technology
    • Practice Management
  • Diversity
  • Career
    • Leadership
    • Education
    • Movers and Shakers
    • Career
    • Learning Portal
    • The Hospital Leader Blog
  • Pediatrics
  • HM Voices
    • Commentary
    • In Your Eyes
    • In Your Words
    • The Flipside
  • SHM Resources
    • Society of Hospital Medicine
    • Journal of Hospital Medicine
    • SHM Career Center
    • SHM Converge
    • Join SHM
    • Converge Coverage
    • SIG Spotlight
    • Chapter Spotlight
    • #JHM Chat
  • Industry Content
    • Patient Monitoring with Tech
An Official Publication of
  • Clinical
    • In the Literature
    • Key Clinical Questions
    • Interpreting Diagnostic Tests
    • Coding Corner
    • Clinical
    • Clinical Guidelines
    • COVID-19
    • POCUS
  • Practice Management
    • Quality
    • Public Policy
    • How We Did It
    • Key Operational Question
    • Technology
    • Practice Management
  • Diversity
  • Career
    • Leadership
    • Education
    • Movers and Shakers
    • Career
    • Learning Portal
    • The Hospital Leader Blog
  • Pediatrics
  • HM Voices
    • Commentary
    • In Your Eyes
    • In Your Words
    • The Flipside
  • SHM Resources
    • Society of Hospital Medicine
    • Journal of Hospital Medicine
    • SHM Career Center
    • SHM Converge
    • Join SHM
    • Converge Coverage
    • SIG Spotlight
    • Chapter Spotlight
    • #JHM Chat
  • Industry Content
    • Patient Monitoring with Tech

Comparing in-hospital adverse events in elderly postoperative delirium patients: haloperidol versus atypical antipsychotics

Clinical question: Are in-hospital adverse events worse in post-operative delirium patients treated with haloperidol compared to atypical antipsychotics?

Background: Post-operative delirium is common in the elderly and can lead to prolonged length of stay, institutional discharge, and increased healthcare costs. While non-pharmacological management is preferred, antipsychotics are commonly used in this population. Over the years, the use of haloperidol has declined, and there is a rise in the use of atypical antipsychotics, particularly in the elderly. This retrospective study looked at in-hospital adverse events, including death, cardiac arrhythmia, pneumonia, stroke, and transient ischemic attack in patients treated with haloperidol, olanzapine, quetiapine, and risperidone for postoperative delirium.

Study design: Retrospective cohort study

Setting: Premier healthcare database which includes 900 hospitals

Synopsis: The study population included patients over the age of 65 undergoing major surgery, as defined by AHRQ procedure classification. Patients who received antipsychotics on or before the day of surgery, had indications for antipsychotics for other diagnoses, or received medications seven days or more after surgery or via parenteral route were excluded. 17,115 patients were analyzed using propensity-score-based overlap weighting. Patients treated with haloperidol were older and had higher medical acuity. The risk of death for patients treated with haloperidol was 3.0% compared to 3.3%, 2.6 %, and 2.8% for risperidone, quetiapine, and olanzapine respectively, with no statistically significant difference. The differences in secondary outcomes, including cardiac arrhythmia, pneumonia, stroke, or transient ischemic attack (TIA) were also not statistically significant.

Bottom line: The risk of in-hospital death, cardiac arrhythmia, pneumonia, and stroke or TIA was similar in elderly patients treated with haloperidol, olanzapine, risperidone, or quetiapine for post-surgical delirium.

Citation: Kim DH, Lee SB, et al. Comparative safety analysis of oral antipsychotics for in-hospital adverse clinical events in older adults after major surgery: a nationwide cohort study. Ann Intern Med. 2023;176(9):1153-62.

Dr. Shenoy

Dr. Shenoy

Dr. Shenoy is the associate chief of hospital medicine at Mount Sinai West, and an associate professor of medicine at Icahn School of Medicine at Mount Sinai in New York.

  • Comparing in-hospital adverse events in elderly postoperative delirium patients: haloperidol versus atypical antipsychotics

    June 3, 2024

  • Hydrocortisone reduces mortality in severe CAP

    June 3, 2024

  • SHM 2024 Awards of Excellence and Junior Investigator Award

    June 3, 2024

  • Celebrating the 2023 Chapter Excellence Status Awards Recipients

    June 3, 2024

  • Aiming for Equitable Care for Transgender Patients

    June 3, 2024

  • Facing the Inevitable: Cyberattacks in Healthcare

    June 3, 2024

  • Chapter Spotlight: Pee Dee

    June 3, 2024

  • What is the Best Initial Management of a Pressure Injury?

    June 3, 2024

  • SIG Spotlight: Patient Experience

    June 3, 2024

  • Dr. Shi Revels in the Diversity of Experiences and Opportunities in HM

    May 3, 2024

1 … 33 34 35 36 37 … 973
  • About The Hospitalist
  • Contact Us
  • The Editors
  • Editorial Board
  • Authors
  • Publishing Opportunities
  • Subscribe
  • Advertise
  • Copyright © 2025 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies.
    ISSN 1553-085X
  • Privacy Policy
  • Terms and Conditions
  • SHM’s DE&I Statement
  • Cookie Preferences